Sphera Funds Management
Latest statistics and disclosures from Sphera Funds Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TEVA, SMH, BBIO, SNY, CYTK, and represent 23.99% of Sphera Funds Management's stock portfolio.
- Added to shares of these 10 stocks: SMH (+$39M), BBIO (+$12M), QQQ (+$11M), SKYE (+$10M), ASML (+$10M), AAPL (+$9.3M), AMZN (+$9.1M), CRM (+$8.6M), CATX (+$7.8M), PRAX (+$7.5M).
- Started 32 new stock positions in KLAC, LHX, ADI, GLUE, CRM, CATX, SKYE, ARWR, NVDA, SVRA.
- Reduced shares in these 10 stocks: , TEVA (-$16M), , Fusion Pharmaceuticals (-$9.6M), CAMT (-$9.1M), , S (-$5.6M), MRK (-$5.4M), BIIB (-$5.4M), GLBE (-$5.1M).
- Sold out of its positions in AMD, ALNY, Alpine Immune Sciences, ANRO, ANNX, CRBP, FIVN, Fusion Pharmaceuticals, GERN, INCY. IsoRay, XBI, Selecta Biosciences, SEDG, NVMI, ESTC.
- Sphera Funds Management was a net buyer of stock by $64M.
- Sphera Funds Management has $733M in assets under management (AUM), dropping by 3.02%.
- Central Index Key (CIK): 0001496201
Tip: Access up to 7 years of quarterly data
Positions held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 113 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 9.0 | $66M | -19% | 4.1M | 16.25 |
|
| Vaneck Etf Trust Semiconductr Etf Put Option (SMH) | 5.3 | $39M | NEW | 150k | 260.70 |
|
| Bridgebio Pharma (BBIO) | 3.9 | $28M | +75% | 1.1M | 25.33 |
|
| Sanofi Sponsored Adr (SNY) | 3.0 | $22M | -10% | 450k | 48.52 |
|
| Cytokinetics Com New (CYTK) | 2.8 | $21M | +36% | 385k | 54.18 |
|
| Amazon (AMZN) | 2.7 | $20M | +86% | 101k | 193.25 |
|
| Nice Sponsored Adr (NICE) | 2.7 | $20M | +32% | 114k | 171.97 |
|
| Syndax Pharmaceuticals (SNDX) | 2.3 | $17M | 822k | 20.53 |
|
|
| Meta Platforms Cl A (META) | 2.3 | $17M | +31% | 33k | 504.22 |
|
| Sarepta Therapeutics (SRPT) | 2.1 | $16M | +77% | 99k | 158.00 |
|
| Praxis Precision Medicines I Com New (PRAX) | 2.0 | $15M | +102% | 358k | 41.36 |
|
| Astrazeneca Sponsored Adr (AZN) | 2.0 | $15M | 190k | 77.99 |
|
|
| Microsoft Corporation (MSFT) | 2.0 | $15M | +19% | 33k | 446.95 |
|
| Apple (AAPL) | 1.8 | $13M | +251% | 62k | 210.62 |
|
| Kura Oncology (KURA) | 1.7 | $13M | 611k | 20.59 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 1.6 | $12M | 294k | 41.10 |
|
|
| Eli Lilly & Co. (LLY) | 1.6 | $12M | -7% | 13k | 905.38 |
|
| Celldex Therapeutics Com New (CLDX) | 1.6 | $11M | +11% | 309k | 37.01 |
|
| Novo-nordisk A S Adr (NVO) | 1.5 | $11M | -6% | 78k | 142.74 |
|
| Biogen Idec (BIIB) | 1.5 | $11M | -32% | 47k | 231.82 |
|
| Invesco Qqq Tr Unit Ser 1 Call Option (QQQ) | 1.5 | $11M | NEW | 23k | 479.11 |
|
| Skye Bioscience Com New (SKYE) | 1.4 | $10M | NEW | 1.3M | 8.01 |
|
| Jasper Therapeutics Com New (JSPR) | 1.4 | $10M | -10% | 454k | 22.70 |
|
| Johnson & Johnson (JNJ) | 1.4 | $10M | -12% | 70k | 146.16 |
|
| Asml Holding N V N Y Registry Shs (ASML) | 1.4 | $10M | NEW | 9.9k | 1022.73 |
|
| Merus N V (MRUS) | 1.2 | $8.7M | 148k | 59.17 |
|
|
| salesforce (CRM) | 1.2 | $8.6M | NEW | 34k | 257.10 |
|
| Immatics SHS (IMTX) | 1.2 | $8.5M | +9% | 731k | 11.62 |
|
| Perspective Therapeutics Com New (CATX) | 1.1 | $7.8M | NEW | 787k | 9.97 |
|
| Pharvaris N V (PHVS) | 1.0 | $7.6M | +2% | 403k | 18.80 |
|
| Merck & Co (MRK) | 1.0 | $7.4M | -42% | 60k | 123.80 |
|
| Rezolute Com New (RZLT) | 1.0 | $7.3M | +71% | 1.7M | 4.30 |
|
| Cybin Ord (CYBN) | 0.9 | $6.9M | 26M | 0.27 |
|
|
| Vigil Neuroscience (VIGL) | 0.9 | $6.8M | -2% | 1.7M | 4.00 |
|
| Ionis Pharmaceuticals (IONS) | 0.9 | $6.7M | NEW | 140k | 47.66 |
|
| Inozyme Pharma (INZY) | 0.9 | $6.5M | +6% | 1.5M | 4.46 |
|
| Abbvie (ABBV) | 0.9 | $6.5M | 38k | 171.52 |
|
|
| Palo Alto Networks (PANW) | 0.8 | $6.1M | NEW | 18k | 339.01 |
|
| Sentinelone Cl A (S) | 0.8 | $6.0M | -48% | 284k | 21.05 |
|
| Tower Semiconductor Shs New (TSEM) | 0.8 | $5.9M | -16% | 150k | 39.31 |
|
| Applied Materials (AMAT) | 0.8 | $5.8M | -23% | 25k | 235.99 |
|
| 4068594 Enphase Energy (ENPH) | 0.8 | $5.7M | +20% | 57k | 99.71 |
|
| Novartis Sponsored Adr (NVS) | 0.7 | $5.3M | 50k | 106.46 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 0.7 | $5.3M | +45% | 328k | 16.25 |
|
| Mineralys Therapeutics (MLYS) | 0.7 | $5.2M | -32% | 443k | 11.70 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.7 | $5.1M | +49% | 243k | 20.99 |
|
| Micron Technology (MU) | 0.7 | $4.9M | NEW | 37k | 131.53 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.7 | $4.8M | -29% | 348k | 13.78 |
|
| Catalyst Pharmaceutical Partners (CPRX) | 0.6 | $4.5M | 288k | 15.49 |
|
|
| Rocket Pharmaceuticals (RCKT) | 0.6 | $4.5M | +12% | 207k | 21.53 |
|
| Jfrog Ord Shs (FROG) | 0.6 | $4.4M | -47% | 118k | 37.55 |
|
| 89bio (ETNB) | 0.6 | $4.2M | +2% | 527k | 8.01 |
|
| Outlook Therapeutics (OTLK) | 0.6 | $4.2M | 571k | 7.38 |
|
|
| Wix SHS (WIX) | 0.5 | $4.0M | -52% | 25k | 159.07 |
|
| Lam Research Corporation (LRCX) | 0.5 | $3.9M | NEW | 3.7k | 1064.85 |
|
| Savara (SVRA) | 0.5 | $3.9M | NEW | 963k | 4.03 |
|
| GSK Sponsored Adr (GSK) | 0.5 | $3.9M | 100k | 38.50 |
|
|
| Qualcomm (QCOM) | 0.5 | $3.7M | +25% | 19k | 199.18 |
|
| Eledon Pharmaceuticals (ELDN) | 0.5 | $3.4M | NEW | 1.3M | 2.64 |
|
| Akero Therapeutics (AKRO) | 0.5 | $3.3M | -11% | 142k | 23.46 |
|
| Shl Telemedicine Sponsored Ads (SHLT) | 0.4 | $3.2M | 633k | 5.10 |
|
|
| Applied Therapeutics (APLT) | 0.4 | $3.1M | +8% | 674k | 4.67 |
|
| Intellia Therapeutics (NTLA) | 0.4 | $3.1M | NEW | 139k | 22.38 |
|
| Broadcom (AVGO) | 0.4 | $3.1M | +1834% | 19k | 160.55 |
|
| Analog Devices (ADI) | 0.4 | $3.0M | NEW | 13k | 228.26 |
|
| Ptc Therapeutics I (PTCT) | 0.4 | $2.9M | NEW | 94k | 30.58 |
|
| Vistagen Therapeutics Ord (VTGN) | 0.4 | $2.8M | 809k | 3.48 |
|
|
| Pliant Therapeutics (PLRX) | 0.4 | $2.8M | 259k | 10.75 |
|
|
| Alector (ALEC) | 0.4 | $2.8M | +8% | 610k | 4.54 |
|
| Enlight Renewable Energy SHS (ENLT) | 0.4 | $2.7M | 169k | 16.16 |
|
|
| Promis Neurosciences Com New (PMN) | 0.4 | $2.7M | 1.8M | 1.50 |
|
|
| Kla Corp Com New (KLAC) | 0.4 | $2.7M | NEW | 3.3k | 824.51 |
|
| Springworks Therapeutics (SWTX) | 0.4 | $2.6M | 70k | 37.67 |
|
|
| Disc Medicine (IRON) | 0.4 | $2.6M | -21% | 58k | 45.07 |
|
| Cargo Therapeutics (CRGX) | 0.3 | $2.6M | +107% | 156k | 16.42 |
|
| Pfizer (PFE) | 0.3 | $2.5M | 90k | 27.98 |
|
|
| NVIDIA Corporation (NVDA) | 0.3 | $2.5M | NEW | 20k | 123.54 |
|
| Global E Online SHS (GLBE) | 0.3 | $2.4M | -67% | 67k | 36.27 |
|
| Ventyx Biosciences (VTYX) | 0.3 | $2.3M | +2% | 1.0M | 2.31 |
|
| Taboola.com Ord Shs (TBLA) | 0.3 | $2.3M | -43% | 667k | 3.44 |
|
| Larimar Therapeutics (LRMR) | 0.3 | $2.3M | NEW | 313k | 7.25 |
|
| L3harris Technologies (LHX) | 0.3 | $2.2M | NEW | 10k | 224.58 |
|
| Adc Therapeutics Sa SHS (ADCT) | 0.3 | $2.2M | NEW | 686k | 3.16 |
|
| Nutrien (NTR) | 0.3 | $2.1M | +13% | 41k | 50.91 |
|
| Perion Network Shs New (PERI) | 0.3 | $2.0M | NEW | 235k | 8.35 |
|
| Kyverna Therapeutics (KYTX) | 0.2 | $1.8M | NEW | 236k | 7.50 |
|
| Alumis (ALMS) | 0.2 | $1.7M | NEW | 125k | 13.30 |
|
| Eliem Therapeutics (ELYM) | 0.2 | $1.5M | NEW | 215k | 7.11 |
|
| Werewolf Therapeutics (HOWL) | 0.2 | $1.5M | 627k | 2.44 |
|
|
| Astria Therapeutics (ATXS) | 0.2 | $1.5M | +44% | 163k | 9.10 |
|
| Vir Biotechnology (VIR) | 0.2 | $1.4M | NEW | 162k | 8.90 |
|
| Monte Rosa Therapeutics (GLUE) | 0.2 | $1.4M | NEW | 375k | 3.74 |
|
| Marvell Technology (MRVL) | 0.2 | $1.4M | NEW | 20k | 69.90 |
|
| Upwork (UPWK) | 0.2 | $1.3M | 117k | 10.75 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $1.3M | NEW | 48k | 25.99 |
|
| Compugen Ord (CGEN) | 0.2 | $1.2M | -3% | 739k | 1.68 |
|
| Kezar Life Sciences (KZR) | 0.2 | $1.2M | 2.1M | 0.60 |
|
|
| Insmed Com Par $.01 (INSM) | 0.2 | $1.1M | -40% | 17k | 67.00 |
|
| Aprea Therapeutics Com New (APRE) | 0.1 | $1.1M | 270k | 4.07 |
|
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.1 | $982k | NEW | 5.7k | 173.81 |
|
| Elevation Oncology (ELEV) | 0.1 | $891k | -23% | 330k | 2.70 |
|
| Varonis Sys (VRNS) | 0.1 | $768k | -20% | 16k | 47.97 |
|
| Cartesian Therapeutics Com New (RNAC) | 0.1 | $677k | NEW | 25k | 27.01 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.1 | $669k | NEW | 1.6k | 430.04 |
|
| Lava Therapeutics Nv SHS (LVTX) | 0.1 | $662k | 368k | 1.80 |
|
|
| Prime Medicine (PRME) | 0.1 | $655k | -37% | 127k | 5.14 |
|
| Icl Group SHS (ICL) | 0.1 | $459k | -17% | 107k | 4.28 |
|
| Fulcrum Therapeutics Put Option (FULC) | 0.0 | $366k | NEW | 59k | 6.20 |
|
| Immatics *w Exp 07/01/202 (IMTXW) | 0.0 | $277k | 100k | 2.77 |
|
|
| Camtek Ord (CAMT) | 0.0 | $243k | -97% | 1.9k | 125.24 |
|
| Gossamer Bio (GOSS) | 0.0 | $200k | -78% | 222k | 0.90 |
|
| Arbe Robotics Ordinary Shares (ARBE) | 0.0 | $82k | 43k | 1.91 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 0.0 | $69k | -92% | 36k | 1.90 |
|
Past Filings by Sphera Funds Management
SEC 13F filings are viewable for Sphera Funds Management going back to 2013
- Sphera Funds Management 2024 Q2 filed Aug. 14, 2024
- Sphera Funds Management 2024 Q1 filed May 15, 2024
- Sphera Funds Management 2023 Q4 restated filed Feb. 15, 2024
- Sphera Funds Management 2023 Q4 filed Feb. 14, 2024
- Sphera Funds Management 2023 Q3 filed Nov. 14, 2023
- Sphera Funds Management 2023 Q2 filed Aug. 14, 2023
- Sphera Funds Management 2023 Q1 filed May 15, 2023
- Sphera Funds Management 2022 Q4 filed Feb. 14, 2023
- Sphera Funds Management 2022 Q3 filed Nov. 14, 2022
- Sphera Funds Management 2022 Q2 filed Aug. 15, 2022
- Sphera Funds Management 2022 Q1 filed May 16, 2022
- Sphera Funds Management 2021 Q4 filed Feb. 14, 2022
- Sphera Funds Management 2021 Q3 filed Nov. 15, 2021
- Sphera Funds Management 2021 Q2 filed Aug. 17, 2021
- Sphera Funds Management 2021 Q1 filed May 17, 2021
- Sphera Funds Management 2020 Q4 filed Feb. 16, 2021